Since ACE inhibitors is widely used for cardiovascular diseases, our findings suggest that clinical use of ACE inhibitors may increase the incidence or the progression of HCC due to their potential roles in enhancing tumor glucose metabolism. The gene discussed is ACE; the disease is cardiovascular disorder.